Psychiatrist

Angeliki Pesiridou

1 Medical Center Blvd, Chester, Pennsylvania, 19013-3902

About Angeliki Pesiridou

Angeliki Pesiridou is a psychiatrist based in Chester, Pennsylvania who is specialized in Psychiatry. Active license number of Angeliki Pesiridou is MD447595 for Psychiatry in Pennsylvania. Her current practice location is 1 Medical Center Blvd, Chester. Patients can contact her at 610-619-8441. Angeliki Pesiridou NPI number (Unique professional ID assigned by NPPES) is 1487967345.

Angeliki Pesiridou specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Practice Information

Angeliki Pesiridou's specialty, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.

Provider Name Angeliki Pesiridou
Specialization Psychiatry
Gender Female
Practice Address: 1 Medical Center Blvd,
Chester, PA - 19013-3902

Professional Identification Codes

NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to healthcare providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.

NPI Number1487967345
NPI Enumeration Date: 21 Jul, 2010
NPI Last Update On: 16 Mar, 2020

Medical Licenses:

Healthcare professionals can hold one or more medical licenses for different specialties in the same state or different states. Related medical licenses for Angeliki Pesiridou are as mentioned below.

License NumberSpecializationStateStatus
MD447595Psychiatry PennsylvaniaPrimary
282370Psychiatry New YorkSecondary

Mailing Address

Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned Practice address.

Angeliki Pesiridou
1 Medical Center Blvd,
Chester, PA - 19013-3902

Book an Appointment with Angeliki Pesiridou

To schedule an appointment, contact Angeliki Pesiridou at 1 Medical Center Blvd, Chester, Pennsylvania or call the phone number listed below.

Book an Appointment

Frequently Asked Questions

Below are some commonly asked questions about Angeliki Pesiridou:

Angeliki Pesiridou is a psychiatrist specializing in Psychiatry. She specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

Yes, Angeliki Pesiridou is currently accepting new patients. To schedule an appointment, contact the office directly and schedule an appointment.
*Availability may change. Please contact the office directly to ask about appointments.

Angeliki Pesiridou practices at 1 Medical Center Blvd, Chester, Pennsylvania, 19013-3902.

To schedule an appointment with Angeliki Pesiridou, please contact the office at 610-619-8441.

Reviews & Feedback

Have you visited Angeliki Pesiridou? Share your experience to help others looking for a psychiatrist in Chester, PA.

Read Reviews / Give Feedback
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 September, 2026.